BIIB vs IDT · P/E 21, rev $9.89B vs P/E 17, rev $1.23B
Biogen Inc (BIIB) versus IDT Corporation (IDT) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
IDT Corporation (IDT) is a telecom services company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported IDT revenue for 2025-07-31 was $1.23B. Net income was $81.1M. IDT currently screens at market cap $1.66B and trailing P/E 17.4.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. IDT currently screens at market cap $1.66B and trailing P/E 17.4.
Not investment advice. Open the BIIB and IDT stock pages for the full models.
Not investment advice.